{"id":"NCT00356278","sponsor":"Emory University","briefTitle":"D-cycloserine and Virtual Reality Exposure to Treat Iraq War Veterans With PTSD","officialTitle":"A Cognitive Enhancer May Facilitate Behavioral Exposure Therapy for Veterans With PTSD","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2006-09","primaryCompletion":"2014-06","completion":"2014-06","firstPosted":"2006-07-25","resultsPosted":"2014-11-19","lastUpdate":"2016-01-08"},"enrollment":156,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Stress Disorder, Post Traumatic"],"interventions":[{"type":"DRUG","name":"D-Cycloserine","otherNames":[]},{"type":"DRUG","name":"Alprazolam","otherNames":["Xanax"]},{"type":"BEHAVIORAL","name":"Virtual Reality Exposure Therapy","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"A","type":"EXPERIMENTAL"},{"label":"B","type":"ACTIVE_COMPARATOR"},{"label":"C","type":"PLACEBO_COMPARATOR"}],"summary":"This study will determine whether a combination of virtual reality exposure therapy and D-cycloserine will reduce post-traumatic stress disorder symptoms in Iraq war veterans.","primaryOutcome":{"measure":"Clinician-Administered PTSD Scale (CAPS)","timeFrame":"Baseline","effectByArm":[{"arm":"VRE Therapy and D-cycloserine","deltaMin":85.3,"sd":null},{"arm":"VRE Therapy and Alprazolam","deltaMin":88,"sd":null},{"arm":"VRE Therapy and Placebo","deltaMin":82.6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"21 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":7},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["30059794","27183343","24743802"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":53},"commonTop":[]}}